nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—ABCG2—Topotecan—peripheral nervous system neoplasm	0.118	0.176	CbGbCtD
Riluzole—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.102	0.151	CbGbCtD
Riluzole—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0873	0.13	CbGbCtD
Riluzole—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.082	0.122	CbGbCtD
Riluzole—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0505	0.0752	CbGbCtD
Riluzole—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0488	0.0726	CbGbCtD
Riluzole—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0471	0.0701	CbGbCtD
Riluzole—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0463	0.0689	CbGbCtD
Riluzole—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.039	0.0581	CbGbCtD
Riluzole—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0316	0.047	CbGbCtD
Riluzole—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0191	0.0284	CbGbCtD
Riluzole—SLC7A11—forelimb zeugopod—peripheral nervous system neoplasm	0.0136	0.68	CbGeAlD
Riluzole—SLC7A11—tongue—peripheral nervous system neoplasm	0.00367	0.183	CbGeAlD
Riluzole—SLC7A11—cerebellum—peripheral nervous system neoplasm	0.000794	0.0396	CbGeAlD
Riluzole—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	0.000599	0.0299	CbGeAlD
Riluzole—ABCG2—parotid gland—peripheral nervous system neoplasm	0.000565	0.0282	CbGeAlD
Riluzole—CYP1A1—parotid gland—peripheral nervous system neoplasm	0.000537	0.0267	CbGeAlD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—LIN28B—peripheral nervous system neoplasm	0.0005	0.144	CbGpPWpGaD
Riluzole—ABCG2—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.000324	0.0934	CbGpPWpGaD
Riluzole—ABCG2—cerebellum—peripheral nervous system neoplasm	0.000262	0.013	CbGeAlD
Riluzole—ABCG2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000189	0.0544	CbGpPWpGaD
Riluzole—ABCG2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.000186	0.0536	CbGpPWpGaD
Riluzole—SCN5A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.000163	0.0471	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00016	0.0461	CbGpPWpGaD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—NCAM1—peripheral nervous system neoplasm	0.000128	0.037	CbGpPWpGaD
Riluzole—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	8.84e-05	0.0255	CbGpPWpGaD
Riluzole—SCN5A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	7.98e-05	0.023	CbGpPWpGaD
Riluzole—Asthenia—Vincristine—peripheral nervous system neoplasm	7.97e-05	0.000262	CcSEcCtD
Riluzole—Pneumonia—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000261	CcSEcCtD
Riluzole—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.00026	CcSEcCtD
Riluzole—Infestation—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.00026	CcSEcCtD
Riluzole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	7.91e-05	0.00026	CcSEcCtD
Riluzole—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000259	CcSEcCtD
Riluzole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	7.89e-05	0.000259	CcSEcCtD
Riluzole—Rash—Dactinomycin—peripheral nervous system neoplasm	7.84e-05	0.000258	CcSEcCtD
Riluzole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.83e-05	0.000257	CcSEcCtD
Riluzole—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	7.8e-05	0.000256	CcSEcCtD
Riluzole—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	7.77e-05	0.000255	CcSEcCtD
Riluzole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	7.77e-05	0.000255	CcSEcCtD
Riluzole—Fatigue—Etoposide—peripheral nervous system neoplasm	7.76e-05	0.000255	CcSEcCtD
Riluzole—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.000255	CcSEcCtD
Riluzole—Stomatitis—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000253	CcSEcCtD
Riluzole—Jaundice—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000253	CcSEcCtD
Riluzole—Pain—Etoposide—peripheral nervous system neoplasm	7.7e-05	0.000253	CcSEcCtD
Riluzole—Constipation—Etoposide—peripheral nervous system neoplasm	7.7e-05	0.000253	CcSEcCtD
Riluzole—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	7.69e-05	0.000253	CcSEcCtD
Riluzole—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000252	CcSEcCtD
Riluzole—Dysuria—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000252	CcSEcCtD
Riluzole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	7.63e-05	0.00025	CcSEcCtD
Riluzole—SLC7A11—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	7.61e-05	0.022	CbGpPWpGaD
Riluzole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	7.6e-05	0.00025	CcSEcCtD
Riluzole—Sweating—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.000249	CcSEcCtD
Riluzole—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	0.000249	CcSEcCtD
Riluzole—Haematuria—Epirubicin—peripheral nervous system neoplasm	7.55e-05	0.000248	CcSEcCtD
Riluzole—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000246	CcSEcCtD
Riluzole—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000246	CcSEcCtD
Riluzole—Weight increased—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000245	CcSEcCtD
Riluzole—Epistaxis—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000245	CcSEcCtD
Riluzole—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.000244	CcSEcCtD
Riluzole—Sinusitis—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.000244	CcSEcCtD
Riluzole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	7.42e-05	0.000244	CcSEcCtD
Riluzole—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.39e-05	0.000243	CcSEcCtD
Riluzole—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	7.38e-05	0.000243	CcSEcCtD
Riluzole—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000242	CcSEcCtD
Riluzole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	7.36e-05	0.000242	CcSEcCtD
Riluzole—Dizziness—Vincristine—peripheral nervous system neoplasm	7.35e-05	0.000241	CcSEcCtD
Riluzole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.33e-05	0.000241	CcSEcCtD
Riluzole—Infestation—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.00024	CcSEcCtD
Riluzole—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.00024	CcSEcCtD
Riluzole—Rash—Alitretinoin—peripheral nervous system neoplasm	7.27e-05	0.000239	CcSEcCtD
Riluzole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.27e-05	0.000239	CcSEcCtD
Riluzole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	7.24e-05	0.000238	CcSEcCtD
Riluzole—Bradycardia—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.000237	CcSEcCtD
Riluzole—Headache—Alitretinoin—peripheral nervous system neoplasm	7.23e-05	0.000237	CcSEcCtD
Riluzole—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000236	CcSEcCtD
Riluzole—Urticaria—Etoposide—peripheral nervous system neoplasm	7.15e-05	0.000235	CcSEcCtD
Riluzole—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	7.14e-05	0.000234	CcSEcCtD
Riluzole—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	7.14e-05	0.000234	CcSEcCtD
Riluzole—Jaundice—Doxorubicin—peripheral nervous system neoplasm	7.14e-05	0.000234	CcSEcCtD
Riluzole—Rhinitis—Epirubicin—peripheral nervous system neoplasm	7.12e-05	0.000234	CcSEcCtD
Riluzole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	7.12e-05	0.000234	CcSEcCtD
Riluzole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.12e-05	0.000234	CcSEcCtD
Riluzole—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	7.12e-05	0.000234	CcSEcCtD
Riluzole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	7.1e-05	0.000233	CcSEcCtD
Riluzole—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	7.1e-05	0.000233	CcSEcCtD
Riluzole—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	7.07e-05	0.000232	CcSEcCtD
Riluzole—Vomiting—Vincristine—peripheral nervous system neoplasm	7.07e-05	0.000232	CcSEcCtD
Riluzole—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.05e-05	0.000232	CcSEcCtD
Riluzole—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	7.05e-05	0.000232	CcSEcCtD
Riluzole—Sweating—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000231	CcSEcCtD
Riluzole—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.00023	CcSEcCtD
Riluzole—Rash—Vincristine—peripheral nervous system neoplasm	7.01e-05	0.00023	CcSEcCtD
Riluzole—Dermatitis—Vincristine—peripheral nervous system neoplasm	7e-05	0.00023	CcSEcCtD
Riluzole—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	7e-05	0.00023	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	6.99e-05	0.0202	CbGpPWpGaD
Riluzole—Haematuria—Doxorubicin—peripheral nervous system neoplasm	6.98e-05	0.000229	CcSEcCtD
Riluzole—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	6.98e-05	0.000229	CcSEcCtD
Riluzole—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.000229	CcSEcCtD
Riluzole—Headache—Vincristine—peripheral nervous system neoplasm	6.96e-05	0.000229	CcSEcCtD
Riluzole—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000227	CcSEcCtD
Riluzole—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.000227	CcSEcCtD
Riluzole—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000226	CcSEcCtD
Riluzole—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.85e-05	0.000225	CcSEcCtD
Riluzole—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	6.83e-05	0.000224	CcSEcCtD
Riluzole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.72e-05	0.000221	CcSEcCtD
Riluzole—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	6.72e-05	0.000221	CcSEcCtD
Riluzole—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.00022	CcSEcCtD
Riluzole—Eye disorder—Epirubicin—peripheral nervous system neoplasm	6.64e-05	0.000218	CcSEcCtD
Riluzole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	6.63e-05	0.000218	CcSEcCtD
Riluzole—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.000217	CcSEcCtD
Riluzole—Nausea—Vincristine—peripheral nervous system neoplasm	6.6e-05	0.000217	CcSEcCtD
Riluzole—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	6.59e-05	0.000216	CcSEcCtD
Riluzole—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	6.59e-05	0.000216	CcSEcCtD
Riluzole—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	6.57e-05	0.000216	CcSEcCtD
Riluzole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	6.57e-05	0.000216	CcSEcCtD
Riluzole—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	6.54e-05	0.000215	CcSEcCtD
Riluzole—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	6.52e-05	0.000214	CcSEcCtD
Riluzole—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	6.49e-05	0.000213	CcSEcCtD
Riluzole—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000213	CcSEcCtD
Riluzole—Asthenia—Etoposide—peripheral nervous system neoplasm	6.46e-05	0.000212	CcSEcCtD
Riluzole—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000212	CcSEcCtD
Riluzole—Angiopathy—Epirubicin—peripheral nervous system neoplasm	6.45e-05	0.000212	CcSEcCtD
Riluzole—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000212	CcSEcCtD
Riluzole—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	6.42e-05	0.000211	CcSEcCtD
Riluzole—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.00021	CcSEcCtD
Riluzole—Chills—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000209	CcSEcCtD
Riluzole—Pruritus—Etoposide—peripheral nervous system neoplasm	6.37e-05	0.000209	CcSEcCtD
Riluzole—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000208	CcSEcCtD
Riluzole—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000206	CcSEcCtD
Riluzole—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.25e-05	0.000205	CcSEcCtD
Riluzole—Mental disorder—Epirubicin—peripheral nervous system neoplasm	6.22e-05	0.000204	CcSEcCtD
Riluzole—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000204	CcSEcCtD
Riluzole—Rash—Cisplatin—peripheral nervous system neoplasm	6.2e-05	0.000203	CcSEcCtD
Riluzole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.19e-05	0.000203	CcSEcCtD
Riluzole—Malnutrition—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.000203	CcSEcCtD
Riluzole—SCN5A—Axon guidance—CNTN6—peripheral nervous system neoplasm	6.17e-05	0.0178	CbGpPWpGaD
Riluzole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.16e-05	0.000202	CcSEcCtD
Riluzole—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000202	CcSEcCtD
Riluzole—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.0002	CcSEcCtD
Riluzole—Flatulence—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.0002	CcSEcCtD
Riluzole—Tension—Epirubicin—peripheral nervous system neoplasm	6.07e-05	0.000199	CcSEcCtD
Riluzole—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.06e-05	0.000199	CcSEcCtD
Riluzole—Nervousness—Epirubicin—peripheral nervous system neoplasm	6.01e-05	0.000197	CcSEcCtD
Riluzole—Back pain—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000196	CcSEcCtD
Riluzole—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	5.96e-05	0.000196	CcSEcCtD
Riluzole—Dizziness—Etoposide—peripheral nervous system neoplasm	5.95e-05	0.000196	CcSEcCtD
Riluzole—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	5.95e-05	0.000195	CcSEcCtD
Riluzole—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000195	CcSEcCtD
Riluzole—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000195	CcSEcCtD
Riluzole—Chills—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000194	CcSEcCtD
Riluzole—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000193	CcSEcCtD
Riluzole—Nausea—Cisplatin—peripheral nervous system neoplasm	5.84e-05	0.000192	CcSEcCtD
Riluzole—SLC7A11—NRF2 pathway—HGF—peripheral nervous system neoplasm	5.83e-05	0.0168	CbGpPWpGaD
Riluzole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	5.81e-05	0.000191	CcSEcCtD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—PTPN11—peripheral nervous system neoplasm	5.81e-05	0.0168	CbGpPWpGaD
Riluzole—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.000189	CcSEcCtD
Riluzole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	5.74e-05	0.000188	CcSEcCtD
Riluzole—Vomiting—Etoposide—peripheral nervous system neoplasm	5.72e-05	0.000188	CcSEcCtD
Riluzole—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000188	CcSEcCtD
Riluzole—Anaemia—Epirubicin—peripheral nervous system neoplasm	5.72e-05	0.000188	CcSEcCtD
Riluzole—Agitation—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000187	CcSEcCtD
Riluzole—Rash—Etoposide—peripheral nervous system neoplasm	5.68e-05	0.000186	CcSEcCtD
Riluzole—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.67e-05	0.000186	CcSEcCtD
Riluzole—Headache—Etoposide—peripheral nervous system neoplasm	5.64e-05	0.000185	CcSEcCtD
Riluzole—Flatulence—Doxorubicin—peripheral nervous system neoplasm	5.64e-05	0.000185	CcSEcCtD
Riluzole—Tension—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.000184	CcSEcCtD
Riluzole—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	5.6e-05	0.000184	CcSEcCtD
Riluzole—Malaise—Epirubicin—peripheral nervous system neoplasm	5.58e-05	0.000183	CcSEcCtD
Riluzole—Nervousness—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.000182	CcSEcCtD
Riluzole—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.56e-05	0.000182	CcSEcCtD
Riluzole—Syncope—Epirubicin—peripheral nervous system neoplasm	5.55e-05	0.000182	CcSEcCtD
Riluzole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000182	CcSEcCtD
Riluzole—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000182	CcSEcCtD
Riluzole—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000181	CcSEcCtD
Riluzole—Palpitations—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000179	CcSEcCtD
Riluzole—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.000178	CcSEcCtD
Riluzole—Cough—Epirubicin—peripheral nervous system neoplasm	5.4e-05	0.000177	CcSEcCtD
Riluzole—Convulsion—Epirubicin—peripheral nervous system neoplasm	5.36e-05	0.000176	CcSEcCtD
Riluzole—Nausea—Etoposide—peripheral nervous system neoplasm	5.35e-05	0.000176	CcSEcCtD
Riluzole—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.34e-05	0.000175	CcSEcCtD
Riluzole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.31e-05	0.000174	CcSEcCtD
Riluzole—Anaemia—Doxorubicin—peripheral nervous system neoplasm	5.29e-05	0.000174	CcSEcCtD
Riluzole—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.26e-05	0.000173	CcSEcCtD
Riluzole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.26e-05	0.000173	CcSEcCtD
Riluzole—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.26e-05	0.000173	CcSEcCtD
Riluzole—Agitation—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	0.000173	CcSEcCtD
Riluzole—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.000172	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000172	CcSEcCtD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	5.21e-05	0.015	CbGpPWpGaD
Riluzole—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000171	CcSEcCtD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	5.2e-05	0.015	CbGpPWpGaD
Riluzole—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.16e-05	0.000169	CcSEcCtD
Riluzole—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.15e-05	0.000169	CcSEcCtD
Riluzole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.14e-05	0.000169	CcSEcCtD
Riluzole—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.13e-05	0.000169	CcSEcCtD
Riluzole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000168	CcSEcCtD
Riluzole—Confusional state—Epirubicin—peripheral nervous system neoplasm	5.09e-05	0.000167	CcSEcCtD
Riluzole—Palpitations—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.000166	CcSEcCtD
Riluzole—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.05e-05	0.000166	CcSEcCtD
Riluzole—Oedema—Epirubicin—peripheral nervous system neoplasm	5.05e-05	0.000166	CcSEcCtD
Riluzole—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000165	CcSEcCtD
Riluzole—Infection—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000165	CcSEcCtD
Riluzole—Cough—Doxorubicin—peripheral nervous system neoplasm	4.99e-05	0.000164	CcSEcCtD
Riluzole—Shock—Epirubicin—peripheral nervous system neoplasm	4.97e-05	0.000163	CcSEcCtD
Riluzole—Convulsion—Doxorubicin—peripheral nervous system neoplasm	4.96e-05	0.000163	CcSEcCtD
Riluzole—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	4.95e-05	0.000163	CcSEcCtD
Riluzole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.94e-05	0.000162	CcSEcCtD
Riluzole—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.94e-05	0.000162	CcSEcCtD
Riluzole—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.93e-05	0.000162	CcSEcCtD
Riluzole—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.9e-05	0.000161	CcSEcCtD
Riluzole—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.88e-05	0.00016	CcSEcCtD
Riluzole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4.87e-05	0.00016	CcSEcCtD
Riluzole—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.87e-05	0.00016	CcSEcCtD
Riluzole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.87e-05	0.00016	CcSEcCtD
Riluzole—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000159	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.000159	CcSEcCtD
Riluzole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.000158	CcSEcCtD
Riluzole—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000158	CcSEcCtD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	4.8e-05	0.0138	CbGpPWpGaD
Riluzole—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	4.76e-05	0.000156	CcSEcCtD
Riluzole—Hypotension—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000155	CcSEcCtD
Riluzole—Confusional state—Doxorubicin—peripheral nervous system neoplasm	4.71e-05	0.000155	CcSEcCtD
Riluzole—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000153	CcSEcCtD
Riluzole—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000153	CcSEcCtD
Riluzole—Infection—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000152	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.61e-05	0.0133	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	4.6e-05	0.0133	CbGpPWpGaD
Riluzole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.6e-05	0.000151	CcSEcCtD
Riluzole—Shock—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000151	CcSEcCtD
Riluzole—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.00015	CcSEcCtD
Riluzole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.57e-05	0.00015	CcSEcCtD
Riluzole—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.00015	CcSEcCtD
Riluzole—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.00015	CcSEcCtD
Riluzole—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.54e-05	0.000149	CcSEcCtD
Riluzole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.000149	CcSEcCtD
Riluzole—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000148	CcSEcCtD
Riluzole—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000148	CcSEcCtD
Riluzole—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.000147	CcSEcCtD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	4.47e-05	0.0129	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	4.46e-05	0.0129	CbGpPWpGaD
Riluzole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000146	CcSEcCtD
Riluzole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.44e-05	0.000146	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	4.4e-05	0.0127	CbGpPWpGaD
Riluzole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.39e-05	0.000144	CcSEcCtD
Riluzole—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.000143	CcSEcCtD
Riluzole—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.000143	CcSEcCtD
Riluzole—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000143	CcSEcCtD
Riluzole—Pain—Epirubicin—peripheral nervous system neoplasm	4.32e-05	0.000142	CcSEcCtD
Riluzole—Constipation—Epirubicin—peripheral nervous system neoplasm	4.32e-05	0.000142	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.00014	CcSEcCtD
Riluzole—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000139	CcSEcCtD
Riluzole—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	4.21e-05	0.0122	CbGpPWpGaD
Riluzole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000138	CcSEcCtD
Riluzole—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000137	CcSEcCtD
Riluzole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000137	CcSEcCtD
Riluzole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000136	CcSEcCtD
Riluzole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.000136	CcSEcCtD
Riluzole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.000135	CcSEcCtD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	4.11e-05	0.0118	CbGpPWpGaD
Riluzole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.06e-05	0.000133	CcSEcCtD
Riluzole—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000132	CcSEcCtD
Riluzole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000132	CcSEcCtD
Riluzole—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000132	CcSEcCtD
Riluzole—Pain—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000131	CcSEcCtD
Riluzole—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000131	CcSEcCtD
Riluzole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000131	CcSEcCtD
Riluzole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000131	CcSEcCtD
Riluzole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000126	CcSEcCtD
Riluzole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000125	CcSEcCtD
Riluzole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.72e-05	0.000122	CcSEcCtD
Riluzole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000122	CcSEcCtD
Riluzole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000121	CcSEcCtD
Riluzole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000121	CcSEcCtD
Riluzole—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.62e-05	0.000119	CcSEcCtD
Riluzole—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.57e-05	0.000117	CcSEcCtD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	3.49e-05	0.0101	CbGpPWpGaD
Riluzole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.45e-05	0.000113	CcSEcCtD
Riluzole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	0.000113	CcSEcCtD
Riluzole—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	3.43e-05	0.00991	CbGpPWpGaD
Riluzole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.35e-05	0.00011	CcSEcCtD
Riluzole—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.34e-05	0.00011	CcSEcCtD
Riluzole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000108	CcSEcCtD
Riluzole—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000105	CcSEcCtD
Riluzole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.2e-05	0.000105	CcSEcCtD
Riluzole—Rash—Epirubicin—peripheral nervous system neoplasm	3.18e-05	0.000104	CcSEcCtD
Riluzole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.18e-05	0.000104	CcSEcCtD
Riluzole—Headache—Epirubicin—peripheral nervous system neoplasm	3.16e-05	0.000104	CcSEcCtD
Riluzole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.09e-05	0.000101	CcSEcCtD
Riluzole—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	3.01e-05	0.0087	CbGpPWpGaD
Riluzole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	3.01e-05	0.00869	CbGpPWpGaD
Riluzole—Nausea—Epirubicin—peripheral nervous system neoplasm	3e-05	9.84e-05	CcSEcCtD
Riluzole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	9.75e-05	CcSEcCtD
Riluzole—Rash—Doxorubicin—peripheral nervous system neoplasm	2.94e-05	9.67e-05	CcSEcCtD
Riluzole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.94e-05	9.66e-05	CcSEcCtD
Riluzole—Headache—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	9.61e-05	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.79e-05	0.00806	CbGpPWpGaD
Riluzole—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	9.11e-05	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—KNG1—peripheral nervous system neoplasm	2.59e-05	0.00747	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	2.55e-05	0.00737	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.44e-05	0.00703	CbGpPWpGaD
Riluzole—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	2.33e-05	0.00672	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—GNAS—peripheral nervous system neoplasm	2.27e-05	0.00654	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—HGF—peripheral nervous system neoplasm	2.16e-05	0.00623	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	2.15e-05	0.00621	CbGpPWpGaD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.07e-05	0.00596	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.96e-05	0.00566	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.92e-05	0.00555	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.78e-05	0.00513	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.73e-05	0.005	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	1.72e-05	0.00495	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.67e-05	0.00481	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.58e-05	0.00456	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.57e-05	0.00454	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.47e-05	0.00425	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	1.44e-05	0.00416	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	1.33e-05	0.00384	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.17e-05	0.00339	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.17e-05	0.00338	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.16e-05	0.00334	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.13e-05	0.00327	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.13e-05	0.00326	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	1.05e-05	0.00304	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	1.03e-05	0.00297	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.01e-05	0.00291	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	9.51e-06	0.00274	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—NRAS—peripheral nervous system neoplasm	9.46e-06	0.00273	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	9.38e-06	0.00271	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.83e-06	0.00255	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	8.47e-06	0.00244	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	8.12e-06	0.00234	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	8.01e-06	0.00231	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.93e-06	0.00229	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	7.81e-06	0.00225	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	7.51e-06	0.00217	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.48e-06	0.00216	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	7.37e-06	0.00213	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TP53—peripheral nervous system neoplasm	7.24e-06	0.00209	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.1e-06	0.00205	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.97e-06	0.00201	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—HRAS—peripheral nervous system neoplasm	6.92e-06	0.002	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.59e-06	0.0019	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—AKT1—peripheral nervous system neoplasm	6.11e-06	0.00176	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	5.86e-06	0.00169	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	5.73e-06	0.00165	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.72e-06	0.00165	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	5.49e-06	0.00159	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	5.29e-06	0.00153	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	5.13e-06	0.00148	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.05e-06	0.00146	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	4.33e-06	0.00125	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.2e-06	0.00121	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.18e-06	0.00121	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.13e-06	0.00119	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	4.07e-06	0.00118	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.69e-06	0.00107	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	3.65e-06	0.00105	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	3.5e-06	0.00101	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	3.47e-06	0.001	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	3.37e-06	0.000973	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	3.33e-06	0.00096	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.26e-06	0.000942	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	2.93e-06	0.000846	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.8e-06	0.000807	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	2.76e-06	0.000796	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	2.25e-06	0.00065	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.21e-06	0.000639	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.21e-06	0.000637	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.87e-06	0.00054	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.78e-06	0.000515	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.76e-06	0.000507	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.44e-06	0.000414	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.41e-06	0.000406	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	8.98e-07	0.000259	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	6.08e-07	0.000175	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.87e-07	0.000112	CbGpPWpGaD
